Insmed INSM 深 沪
等待开盘 08-15 09:30:00 美东时间
123.74
-2.590
-2.05%
华盛通- 最 高126.845
- 今 开125.67
- 成交量 195.73万股
- 最 低 122.21
- 昨 收 126.33
- 总市值 270.23亿
- 52周最高 212.75
- 市盈率 静 --
- 换手率 0.90%
- 52周最低 90.39
- 委 比 56.08%
- 总股本 2.18亿
- 历史最高 212.75
- 量 比 0.64
- 振 幅 3.67%
- 历史最低 2.64
- 每 手 1
- 风险率 30.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $169
Wells Fargo analyst Benjamin Burnett maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $161 to $169.
08-07 21:56
美股牛股 | 心血管药企BRVE上市首日飙涨逾65%，超预期募资3.8亿美元；IOVA大涨逾43%，赫兹租车涨近30%
心血管药企BRVE上市首日飙涨逾65%，超预期募资3.8亿美元；IOVA大涨逾43%，Q2亏损大幅收窄；赫兹租车涨近30%，Q2净利实现扭亏为盈>>
08-07 18:53
Insmed shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
Insmed shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
08-06 19:25
Insmed Inc(INSM)股票8月6日盘中上涨31.83%：原因全解读
• 受积极的临床试验数据及潜在收购意向推动，Insmed股价上涨。 • 分析师调整了营收模型，将平均目标价设定为196.74美元。 • 技术指标显示出卖出信号，而该股目前正处于超卖区域。
08-06 19:16
Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M Estimate
Insmed (NASDAQ:INSM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.73) by 91.78 percent. This is a 96.47 percent increase over losses of $(1.70) per share from the same period last year. The company reported quarterly sales of $425.486 million which ...
08-06 19:10
Mckesson Corp Stock (MCK) Moved Down by 3.44% on Aug 6: What Signal Does It Send?
• McKesson shares declined following margin contraction in the U.S. Pharmaceutical segment. • Management maintained full-year earnings guidance, disappointing investors seeking an upward revision. • Regulatory scrutiny regarding drug pricing and reimbursement creates significant uncertainty for the firm.
08-06 15:15
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
07-18 18:30
